Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Quick Stats
Feb 02, 202641.1
AI Score
HOLD1.0
Volume Ratio
Feb 17, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
BBNX Stock Summary
Last updated Feb 02, 2026
BBNX is currently trading at $13.7, positioned below its 200-day moving average of $20.05, suggesting bearish momentum. The stock has a 52-week range of $8.89 to $32.71.
Technical Analysis: The 50-day moving average stands at $25.8, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 21.846, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.292, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BBNX at 41.1/100 with a HOLD recommendation.
BBNX (Beta Bionics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 21.846 |
| CMF (20) | -0.292 |
| ROC (10) | -25.946 |
| ADX (14) | 42.569 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -3.682 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -94.671 |
| MFI (14) | 28.537 |
BBNX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BBNX Price vs Max Options Open Interest
BBNX Max Change In Options Open Interest
BBNX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BBNX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BBNX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BBNX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Beta Bionics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BBNX Moving Averages Analysis
BBNX (Beta Bionics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 15.49 |
| 20 | 19.38 |
| 30 | 23.18 |
| 50 | 25.8 |
| 100 | 24.7 |
| 200 | 20.05 |
BBNX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 608.9 million |
| Earnings/Share ($) | -1.82 |
| Net Proft Margin (%) | -0.8789 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.8929 |
| EPS Estimate Next Year ($) | -1.705 |
| WallStreet Target Price ($) | 30.4546 |
| Most Recent Quarter |